Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT027 in B7-H3-positive Brain Metastases From Advanced Solid Tumors
NCT07897799Phase 2Not yet recruiting
- Sponsor
- Suzhou Maximum Bio-tech
- Start
- Dec 2027
- Primary completion
- Dec 2029
- Countries
- 2
01
Overview
A Phase 2 trial of MT027 CAR-T cells in brain metastases, sponsored by Suzhou Maximum Bio-tech. Planned start Dec 2027; status: not yet recruiting.
02
Drugs
MT027 CAR-T cells
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT07897799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897799.